Cytarabine Injection Shortage
Last Updated: March 29, 2023
Status: Current
Reason for the Shortage
-
- Fresenius Kabi had cytarabine on shortage due to a manufacturing delay.
- Meitheal Pharmaceuticals had cytarabine on shortage due to a manufacturing delay.
- Mylan Institutional has discontinued cytarabine presentations.
- Pfizer had cytarabine on shortage due to increased demand.
Available Products
-
- Cytarabine solution for injection, Fresenius Kabi, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 63323-0120-20
- Cytarabine solution for injection, Meitheal Pharmaceuticals, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 71288-0109-20
- Cytarabine solution for injection, Pfizer, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 61703-0319-22
- Cytarabine solution for injection, Pfizer, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 61703-0304-36
- Cytarabine solution for injection, Pfizer, 20 mg/mL, 5 mL preservative-free vial, 5 count, NDC 61703-0305-38
- Cytarabine solution for injection, Pfizer, 20 mg/mL, 50 mL preservative-free vial, 1 count, NDC 61703-0303-46
Estimated Resupply Dates
-
- All presentations are available.
Updated
Updated March 29, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 1, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.